Showing results (261-270 of 420) with videos related to
Sort By:
Pageof 42
Medical Care Research and Review : MCRR|November 28, 2015
Impact of the Cincinnati Aligning Forces for Quality Multi-Payer Patient Centered Medical Home Pilot on Health Care Quality, Utilization, and CostsMeredith B Rosenthal, Shehnaz Alidina, Mark W Friedberg, et al.Health Services Research|July 20, 2018
Impact of Medicare's Nonpayment Program on Venous Thromboembolism Following Hip and Knee ReplacementsCaroline P Thirukumaran, Laurent G Glance, Meredith B Rosenthal, et al.JAMA Health Forum|May 1, 2026
Primary Care Access and the Role of Telemedicine for Traditional Medicare BeneficiariesIshani Ganguli, Nicholas E Daley, Andrew Hicks, et al.Plos One|November 23, 2013
The ontogeny of bumblebee flight trajectories: from naïve explorers to experienced foragersJuliet L Osborne, Alan Smith, Suzanne J Clark, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 1, 2019
Use and cost of disease-modifying therapies by Sonya Slifka Study participants: has anything really changed since 2000 and 2009?Sarah L Minden, R Philip Kinkel, Helene T Machado, et al.The Journal of Antimicrobial Chemotherapy|September 17, 2014
Strain-specific antiviral activity of iminosugars against human influenza A virusesS Hussain, J L Miller, D J Harvey, et al.Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2005
Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaireHermine I Brunner, Anne L Johnson, Andrea C Barron, et al.Current Eye Research|August 3, 2010
Intraocular properties of a repository urokinase receptor antagonist a36 Peptide in rabbitsIryna A Falkenstein, Lingyun Cheng, Terence R Jones, et al.Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|September 29, 2007
Intraocular properties of an alkoxyalkyl derivative of cyclic 9-(S)-(3-hydroxyl-2-phosphonomehoxypropyl) adenine, an intravitreally injectable anti-HCMV drug in rabbit and guinea pigAjay M Tammewar, Lingyun Cheng, Karl Y Hostetler, et al.JAMA|November 22, 2007
Employers' use of value-based purchasing strategiesMeredith B Rosenthal, Bruce E Landon, Sharon-Lise T Normand, et al.Pageof 42